The Pharmacy business: Owners, Customers, the Government, and the Rules

Australia's pharmacy system is, depending on your vantage point, either a marvel of accessible healthcare or a regulatory carve-up that quietly picks your pocket every time you fill a script. Both descriptions are partially accurate. A new Grattan Institute report leans hard into the second reading, and the evidence it marshals is worth taking seriously. But the story is also older and simpler than the report's reformist framing suggests.

The Guild negotiates for owners, not patients

The Pharmacy Guild of Australia represents pharmacy owners, not pharmacists, and not patients. That distinction matters more than it sounds. The Guild negotiates the terms of pharmacy funding directly with the federal government, under agreements that are, in the Grattan report's description, conducted privately. The outcomes of those negotiations include dispensing fees that Grattan argues are unjustified and probably too high, rules that prevent pharmacies from discounting prescription medicines, and location and ownership restrictions that effectively cap the number of competitors in any given market.

The profit figures tell you which way the deal runs. Pharmacy sector profits have surged. That is not what you would expect from a sector under serious competitive pressure. It is what you would expect from a sector protected from serious competitive pressure.

Democracy's correction mechanism for this is not technocratic. It is not a Grattan report, useful as that report is. It is customers who understand they are being overcharged, who connect that to a specific set of rules, and who complain loudly enough and persistently enough to change the political arithmetic for their elected representatives.

Regulatory capture is the system working as intended, not failing

None of this is unusual, or even particularly sinister, as a political economy story. Regulatory capture, the process by which the industry being regulated ends up shaping the regulation, is not a conspiracy. It is the predictable outcome of a system where one side of a negotiation is organised, funded, and incentivised to show up every single time, and the other side, patients and taxpayers, is diffuse, busy, and rarely paying close attention. The Guild is doing exactly what a well-run industry association should do: extracting the best possible deal for its members. The question is not why the Guild does this. The question is why governments keep agreeing to it.

The answer is also fairly ordinary. Pharmacy owners are small business people distributed across every electorate in the country. They have strong community standing. They are, in many regional and outer-suburban areas, genuinely important local institutions. Any politician proposing to expose them to sharper competition is taking a concentrated hit from an organised constituency in exchange for a diffuse benefit spread across millions of people who will never quite connect cheaper scripts to a regulatory change made three years earlier. The incentives for politicians point toward leaving the system alone.

Grattan's reforms are sound in principle but quiet on transition costs

Grattan's recommendations are sensible on their face: replace Guild negotiations with independent policy decisions, reset dispensing fees based on cost rather than bargaining power, phase out discounting restrictions, and scrap location and ownership rules. The evidence base for most of these is not trivial. Countries with more competitive pharmacy markets do not appear to suffer worse access to medicines. The idea that dispensing fees should reflect the actual cost of dispensing, rather than the Guild's negotiating leverage, is hard to argue with in principle.

Where the report is quieter is on the transition. Pharmacy owners made investment decisions under the existing rules. Many paid significant sums for goodwill in the expectation that location protections would hold. Removing those protections immediately, as the report recommends for ownership and location rules, would shift real losses onto real people who played by the rules as they found them. That does not mean reform is wrong. It means that the design of reform matters, and that acknowledging it is complicated is more honest than treating it as simple.

The pharmacy story is a political economy story

The deeper structural point is this: the system works exactly the way incentivised systems tend to work. The Guild organised. The government responded to the organised. The unorganised, patients and taxpayers, absorbed the cost. That is not a pharmacy story specifically. It is a political economy story that plays out across aged care, childcare, professional licensing, and a dozen other sectors where industry associations punch well above their democratic weight.

Democracy's correction mechanism for this is not technocratic. It is not a Grattan report, useful as that report is. It is customers who understand they are being overcharged, who connect that to a specific set of rules, and who complain loudly enough and persistently enough to change the political arithmetic for their elected representatives. That has happened before in Australian policy, in sectors where the public finally decided the protection of incumbent businesses was coming directly out of their own pockets.

The pharmacy system is not broken. It is working as designed. The question for voters is whether that design still reflects what they want.

Sources

Grattan Institute — Shake up pharmacy policy to give patients a better deal

Frequently Asked Questions

Why are prescription medicines more expensive in Australia than they need to be?
Australia's dispensing fees are set through private negotiations between the federal government and the Pharmacy Guild, which represents pharmacy owners rather than patients. Because those negotiations reflect bargaining power rather than actual dispensing costs, fees end up higher than a competitive market would produce.

What is the Pharmacy Guild of Australia and why does it have so much influence?
The Pharmacy Guild represents pharmacy owners and negotiates funding terms directly with the federal government. Its political influence comes from the fact that pharmacy owners are small business people spread across every electorate, giving them concentrated local standing that makes them difficult for politicians to confront.

Would removing pharmacy location and ownership rules hurt access to medicines in regional areas?
Countries with more competitive pharmacy markets do not appear to suffer worse access to medicines, though the evidence is not exhaustive. The more concrete concern is the transition: owners who paid significant sums for goodwill under existing location protections would face real financial losses if those rules were removed quickly.

What does the Grattan Institute recommend to fix Australia's pharmacy regulations?
Grattan recommends replacing Guild negotiations with independent policy decisions, resetting dispensing fees to reflect actual costs, phasing out rules that prevent pharmacies from discounting prescription medicines, and scrapping location and ownership restrictions that limit competition.

Has Australia ever successfully reformed a sector protected by a powerful industry lobby?
Yes — the article notes this has happened in other Australian policy areas when the public connected high prices to specific rules and sustained enough political pressure to shift the calculus for elected representatives. The mechanism is voter pressure, not technocratic recommendations alone.